Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Public Health topic

No spam. Unsubscribe anytime.

Rules attorney warns of immunity/anti-abrogation issues in opioid-response bill

Arizona House Rules Committee · February 23, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Rules counsel told the committee that House Bill 2697 amends immunity provisions in numerous statutes related to opioid overdose response and recommended drafting amendments to conform language with recent Arizona Supreme Court guidance to avoid anti-abrogation problems.

Tim Fleming, rules attorney, told the committee that House Bill 2697 expands or clarifies the use of opioid antagonists and related emergency responses but modifies statutory immunity language that exists across many places in the Arizona Revised Statutes. "This bill does public policy things having to do with opioid overdose emergencies," Fleming said, and cautioned that recent state supreme court decisions have changed how immunity language must be drafted.

Fleming recommended floor amendments to align the bill’s immunity provisions with current constitutional and statutory frameworks so they do not inadvertently abrogate existing protections or conflict with case law. He said he and proponents have discussed language that would preserve the intent of Good Samaritan–style protections while conforming to judicial guidance.

The committee recommended HB 2697 is constitutional and in proper form by a recorded vote: 4 ayes, 2 nays and 2 absent. Members did not adopt additional floor changes at this meeting but Fleming indicated proposed amendments were under discussion with the sponsor.

Why it matters: The bill touches provider immunities and public-health emergency responses; drafting that is inconsistent with recent judicial decisions can invite litigation or produce unintended gaps in protection for emergency responders and pharmacists.

Next steps: Sponsors and counsel are expected to work on technical amendments before further floor action.